APGE: Apogee Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 3,217.45
Enterprise Value ($M) 3,099.14
Book Value ($M) 379.91
Book Value / Share 6.50
Price / Book 8.47
NCAV ($M) 376.92
NCAV / Share 6.45
Price / NCAV 8.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.22
Return on Assets (ROA) -0.59
Return on Equity (ROE) -0.64

Liquidity (mrq)
Quick Ratio 19.38
Current Ratio 19.38

Balance Sheet (mrq) ($M)
Current Assets 398.41
Assets 401.40
Liabilities 21.49
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -93.00
Net Income -83.98

Cash Flow Statement (mra) ($M)
Cash From Operations -74.76
Cash from Investing -273.91
Cash from Financing 315.39

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-01 13D/A Fairmount Funds Management LLC 9.99 -11.85
02-14 13G/A Deep Track Capital, LP 6.25 -23.15
02-14 13G Ra Capital Management, L.p. 5.30
02-09 13G/A Fmr Llc 13.50 12.84
11-03 13G Access Industries Management, Llc 5.22
07-28 13D Venrock Healthcare Capital Partners III, L.P. 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark one)
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-28 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-12 196,021 196,055 99.98
2024-04-11 91,750 135,640 67.64
2024-04-10 106,322 177,588 59.87
2024-04-09 107,227 151,347 70.85
2024-04-08 82,756 195,953 42.23

(click for more detail)

Similar Companies
ALPN – Alpine Immune Sciences, Inc. ALT – Altimmune, Inc.
ANIP – ANI Pharmaceuticals, Inc. APLT – Applied Therapeutics, Inc.
AQST – Aquestive Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io